Company Filing History:
Years Active: 2022
Title: Sun Chul Hur: Innovator in Thienopyridine Derivatives
Introduction
Sun Chul Hur is a notable inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on thienopyridine derivatives.
Latest Patents
Sun Chul Hur holds a patent for "Thienopyridine derivatives and pharmaceutical composition comprising same." This patent describes a thienopyridine derivative compound represented by Formula 1 or pharmaceutically acceptable salts thereof. The compound exhibits an excellent inhibitory effect on protein kinase activity. Consequently, pharmaceutical compositions containing this thienopyridine compound can be effectively utilized for the prevention or treatment of diseases associated with protein kinase activity. He has 1 patent to his name.
Career Highlights
Sun Chul Hur is currently associated with Wellmarker Bio Co., Ltd., where he continues to advance his research and development efforts. His work has the potential to impact various therapeutic areas, particularly those related to protein kinase activity.
Collaborations
Some of his notable coworkers include Hyunho Lee and Chun-Ho Park. Their collaborative efforts contribute to the innovative environment at Wellmarker Bio Co., Ltd.
Conclusion
Sun Chul Hur's contributions to the field of pharmaceuticals through his patent on thienopyridine derivatives highlight his role as an influential inventor. His work promises to enhance treatment options for diseases linked to protein kinase activity.